Loomis, Sayles & Company’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $11.8M | Buy |
|
|||||
|
2024
Q1 | $11.1M | Buy |
|
|||||
|
2023
Q4 | $11M | Sell |
|
|||||
|
2023
Q3 | $11.5M | Buy |
|
|||||
|
2023
Q2 | $13.6M | Buy |
|
|||||
|
2023
Q1 | $11.2M | Sell |
|
|||||
|
2022
Q4 | $56.8M | Buy |
|
|||||
|
2022
Q3 | $76.5M | Buy |
|
|||||
|
2022
Q2 | $75M | Sell |
|
|||||
|
2022
Q1 | $98.7M | Buy |
|
|||||
|
2021
Q4 | $71.6M | Buy |
|
|||||
|
2021
Q3 | $64.5M | Buy |
|
|||||
|
2021
Q2 | $68.3M | Sell |
|
|||||
|
2021
Q1 | $79.4M | Sell |
|
|||||
|
2020
Q4 | $67.9M | Buy |
|
|||||
|
2020
Q3 | $50.6M | Buy |
|
|||||
|
2020
Q2 | $43.4M | Buy |
|
|||||
|
2020
Q1 | $25.3M | Buy |
|
|||||
|
2019
Q4 | $23.8M | Sell |
|
|||||
|
2019
Q3 | $20M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $2K | Hold |
|
|||||
|
2016
Q2 | $2K | Sell |
|
|||||
|
2016
Q1 | $6K | Buy |
|
|||||
|
2015
Q4 | $3K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $13.6M | Sell |
|
|||||
|
2014
Q2 | $16.5M | Sell |
|
|||||
|
2014
Q1 | $17M | Sell |
|
|||||
|
2013
Q4 | $15.7M | Sell |
|
|||||
|
2013
Q3 | $19.2M | Sell |
|
|||||
|
2013
Q2 | $14.1K | Buy |
|